A-485

N/A

Report date: 2022/05/24 15:09:20
NME

Base Information

Drug NameA-485
Drug Alias NameA-485
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp300-CBP transcription factors inhibitors
Targetsp300-CBP transcription factors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A